technology

CAR-NK cell therapy

Allogeneic NK cells engineered with chimeric antigen receptors for off-the-shelf cancer immunotherapy without GVHD risk.

Where it's used

NK-cell & CAR-NK therapy
CAR-NK and NK-cell therapy — allogeneic, off-the-shelf effector cells with low toxicity (minimal CRS, no GVHD) against solid and haematological cancers; iPSC-NK is the scalable platform.
therapeutics-platforms 4 min